Stem Cell Therapy Market To Reach $1,670.1 Million By 2030

Stem Cell Therapy Market Growth & Trends

The global stem cell therapy market size is anticipated to reach USD 1,670.1 million by 2030 and is projected to grow at a CAGR of 24.15% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is propelled by several key factors that underscore both scientific advancements and evolving healthcare needs.Advancements in stem cell research and technology have revolutionized the landscape of regenerative medicine. Breakthroughs in stem cell isolation, characterization, and manipulation techniques have empowered researchers to harness the therapeutic potential of stem cells with greater precision and efficacy. For instance, in May 2023, EPROCELL introduced Contract Development and Manufacturing Organization (CDMO) services for producing Advanced Therapies Medicinal Products (ATMPs) derived from mesenchymal stem cells (MSC). This expansion is facilitated by a partnership with Histocell. These advancements have spurred the development of innovative therapies targeting a wide spectrum of medical conditions, from chronic diseases to degenerative disorders.

The increasing prevalence of chronic and degenerative diseases has fueled the demand for novel treatment modalities. Conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, and autoimmune diseases pose significant healthcare challenges, driving the search for innovative therapeutic approaches. For instance, a study published in The Lancet Neurology has anticipated a significant increase in the number of individuals affected by Parkinson's disease by the year 2040. The projected figure is alarming, as it suggests that the number of people living with this neurodegenerative disorder may double, reaching at least 12.9 million worldwide. Stem cell therapies hold immense promise in addressing these complex diseases by promoting tissue regeneration, modulating immune responses, and restoring organ function, thus offering new avenues for disease management and treatment.

Investment in the global market has been steadily increasing as investors recognize the potential for groundbreaking medical advancements and lucrative returns. This influx of capital fuels research, development, and commercialization efforts, driving the overall market growth. With a growing emphasis on regenerative medicine and personalized healthcare, the market is poised for continued expansion, offering innovative treatments and renewed hope to patients grappling with a wide range of medical conditions.

 Request a free sample copy or view report summary: Stem Cell Therapy Market Report

Stem Cell Therapy Market Report Highlights

• Based on therapy type, the allogeneic stem cell therapies segment led the market with the largest revenue share of 68.41% by 2023 and is anticipated to grow at the fastest CAGR of 26.74% during the forecast period, propelled by a convergence of factors contributing to its expansion.such as increasing landscape of research and clinical trials within the field

• Based on therapeutic application, the other therapeutic segment including diseases such as blood disorders, and neurological disorders led the market with the largest revenue share of 72.75% in 2023, fueled by ongoing research and clinical advancements

• North America dominated the market with the largest revenue share of 50.11% in 2023 and is anticipated to grow at the fastest CAGR of 28.07% during the forecast period, driven by several key factors. The market growth is facilitated by favorable regulatory frameworks, rising rates of chronic diseases, and technological improvements

Stem Cell Therapy Market Segmentation

Grand View Research has segmented the global stem cell therapy market based on therapy type, therapeutic application, and region:

Stem Cell Therapy Type Outlook (Revenue, USD Million, 2018 - 2030)

• Allogeneic Stem Cell Therapies

• Hematopoietic Stem Cell Therapies

• Mesenchymal Stem Cell Therapies

• Autologous Stem Cell Therapies, by Type

• BM, Blood, & Umbilical Cord-derived Stem Cells

• Adipose-Derived Cells

• Others

Stem Cell Therapy Therapeutic Application Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology

• Cardiovascular Disease (CVD)

• Musculoskeletal Disorders

• Others

Stem Cell Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • Switzerland

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

• Rest of World

List of Key Players in the Stem Cell Therapy Market

• Bluebird bio, Inc.

• NIPRO

• Orchard Therapeutics plc 

• Pharmicell Co., Ltd.

• CorestemChemon Inc.

• ANTEROGEN.CO. LTD.

• Holostem S.r.l.

• Vertex Pharmaceuticals, Inc.

• Cleveland Cord Blood Center

• Gamida Cell Ltd.